NASDAQ:NPCE
NeuroPace, Inc. Stock News
$13.64
-0.260 (-1.87%)
At Close: May 03, 2024
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
04:05pm, Wednesday, 17'th Apr 2024
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
04:05pm, Wednesday, 27'th Mar 2024
MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it
NeuroPace, Inc. (NPCE) Q4 2023 Earnings Call Transcript
09:29pm, Tuesday, 05'th Mar 2024
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
02:00pm, Tuesday, 05'th Mar 2024
One of the best stocks for financial freedom over the past 30 years is Monster Beverage (NASDAQ: MNST ). Between Feb. 14, 1994, and Feb. 14, 2024, the energy drink maker's stock appreciated around 200
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
04:05pm, Thursday, 15'th Feb 2024
MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:30pm, Tuesday, 19'th Dec 2023
MOUNTAIN VIEW, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
08:00am, Tuesday, 21'st Nov 2023
MOUNTAIN VIEW, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace, Inc. (NPCE) Q3 2023 Earnings Call Transcript
09:44pm, Monday, 06'th Nov 2023
NeuroPace, Inc. (NASDAQ:NPCE ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and Head of Investor Relations Joel Becker - Chief E
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
05:01pm, Monday, 16'th Oct 2023
MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
04:05pm, Wednesday, 20'th Sep 2023
MOUNTAIN VIEW, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, to
NeuroPace: A Speculative Epilepsy Play
05:22am, Tuesday, 05'th Sep 2023
NeuroPace aims to improve the lives of epilepsy patients with its remote monitoring system. The company's RNS system offers personalized and real-time treatments for epilepsy patients. NeuroPace has s
NeuroPace to Participate in Upcoming Investor Conferences
04:05pm, Thursday, 24'th Aug 2023
- Wells Fargo 2023 Healthcare Conference - - Morgan Stanley 21 st Annual Global Healthcare Conference - - Lake Street Capital Markets 7 th Annual Best Ideas Growth Conference - MOUNTAIN VIEW, Calif.,
NeuroPace, Inc. (NPCE) Q2 2023 Earnings Call Transcript
10:17am, Friday, 11'th Aug 2023
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and Head of Investor Relations Joel Becker - Chief Exe
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
04:05pm, Tuesday, 18'th Jul 2023
MOUNTAIN VIEW, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace, Inc. (NPCE) CEO Michael Favet on Q1 2023 Results - Earnings Call Transcript
07:42am, Sunday, 07'th May 2023
NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Favet - President & Chief Executive Officer, NeuroPace
